• Cardiovascular Consults™: Focus on Hypertension
  • CME

  • Cardiovascular Consults: Focus on Hypertension

  • Author(s)/Faculty: George L. Bakris, MD, FAHA, FASN; Michael H. Davidson, MD, FACC, FACP, FNLA; William J. Elliott, MD, PhD; Stanley S. Franklin, MD; Richard J. Glassock, MD, MACP; Peter Kowey, MD, FAHA, FACC, FHRS; Peter A. McCullough, MD, MPH, FACC, FACP, FAHA, FCCP; Keith C. Norris, MD, FACP; Katrin Uhlig, MD, MS; William B. White, MD
    Source: Cardiology Today
    Type: Monograph Articles/Items: 7
    Release Date: 12/2/2011 Expiration Date: 12/1/2012
    Credit Type: CME Number of Credit(s): 2
    Cost: Free Provider: UnivOfChicagoLogo

  • Hypertension is associated with increased risk of cardiovascular disease and contributed to approximately 54,186 deaths in 2004. Physicians must be aware of effective strategies to manage hypertension and reduce the burden of this disease. Blood pressure control is suboptimal in patients with hypertension, despite the availability of effective therapies and new clinical evidence to guide management.

Sponsorship Statement: This continuing medical education activity is sponsored by University of Chicago Pritzker School of Medicine

Educational Partner: Vindico Medical Education

Support Statement: This activity is supported by educational grants from
Boehringer Ingelheim Pharmaceuticals, Inc Bristol-Myers Squibb/Pfizer Genentech Takeda Pharmaceuticals LOGOs Takeda Pharmaceuticals LOGOs

Target Audience:
The intended audience for this activity is cardiologists and other healthcare professionals involved in the treatment of patients with hypertension.

Learning Objectives:
At the conclusion of this activity participants should be able to:

  • List key areas of hypertension management that are expected to change with updated clinical guidelines.
  • Incorporate home and ambulatory BP monitoring to enhance BP control.
  • Adjust current antihypertensive regimens to ensure maximum 24-hour BP control.
  • Identify optimal combination antihypertensive regimens for early BP control.
  • Compare the benefits and limitations of diuretics currently used in combination with antihypertensive therapy

Cardiovascular Consults Editorial Board
George L. Bakris, MD, FAHA, FASN
Professor of Medicine
Director, Hypertensive Diseases Unit
University of Chicago Pritzker School of Medicine
Chicago, IL

Michael H. Davidson, MD, FACC, FACP, FNLA
Clinical Professor of Medicine
Director of Preventive Cardiology
University of Chicago Pritzker School of Medicine
Chicago, IL

Peter Kowey, MD, FAHA, FACC, FHRS
President, Main Line Health Center
William Wikoff Smith Chair in Cardiovascular Research
Lankenau Institute for Medical Research
Professor of Medicine and Clinical Pharmacology
Jefferson Medical College
Philadelphia, PA

Cardiovascular Consults Contributing Faculty:
William J. Elliott, MD, PhD
Professor of Preventive Medicine, Internal Medicine & Pharmacology
Head, Division of Pharmacology
Pacific Northwest University of Health
Yakima, WA

Stanley S. Franklin, MD
Clinical Professor of Medicine
University of California, Irvine
Los Angeles, CA

Richard J. Glassock, MD, MACP
Emeritus Professor of Medicine
Geffen School of Medicine
University of California at Los Angeles
Laguna Niguel, CA

Peter A. McCullough, MD, MPH, FACC, FACP, FAHA, FCCP
Consultant Cardiologist
Chief Academic and Scientific Officer
Department of Medicine
Cardiology Section
Providence Park Hospital
Novi, MI

Keith C. Norris, MD
Executive VP for Research and Health Affairs
Charles R. Drew University of Medicine and Science
Assistant Dean for Clinical and Translational Science
Geffen School of Medicine
UCLA
Los Angeles, CA

Katrin Uhlig, MD, MS
Associate Professor of Medicine
Tufts University School of Medicine
Tufts Medical Center
Boston, MA

William B. White, MD
Professor of Medicine
Chief, Division of Hypertension and Clinical Pharmacology
Calhoun Cardiology Center
University of Connecticut
Farmington, CT

Accreditation:
University of Chicago Pritzker School of Medicine is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

Credit Designation
University of Chicago Pritzker School of Medicine designates this enduring material for a maximum of 2.0 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

This enduring material is approved for 1 year from the date of original release, December 2, 2011 to December 1, 2012.

How To Participate in this Activity and Obtain CME Credit:
To participate in this CME activity, you must read the objectives, read the articles, and complete the evaluation. Provide only one (1) correct answer for each question. A satisfactory score is defined as answering 4 of 6 of of the posttest questions correctly. Upon receipt of the completed materials, if a satisfactory score on the posttest is achieved, the University of Chicago will issue an AMA PRA Category 1 Credit(s)™ certificate.

Disclosures:
In accordance with the Accreditation Council for Continuing Medical Education’s Standards for Commercial Support, all CME providers are required to disclose to the activity audience the relevant financial relationships of the planners, teachers, and authors involved in the development of CME content. An individual has a relevant financial relationship if he or she has a financial relationship in any amount occurring in the last 12 months with a commercial interest whose products or services are discussed in the CME activity content over which the individual has control. Relationship information appears on this page and the next page.

The authors disclose that they do have significant financial interests in any products or class of products discussed directly or indirectly in this activity, including research support.

Planning Committee and Faculty members report the following relationship(s):
George L. Bakris, MD, FAHA
Consulting Fees: Abbott, Relapysa, Takeda
Investigator-initiated studies: Forest, Novartis, Pepsico

Michael H. Davidson, MD, FACC, FACP, FNLA
Speakers’ Bureau: Abbott, AstraZeneca, GlaxoSmithKline, Merck
Advisory Board/Consultant: Abbott, Aegerion, Amgen, AstraZeneca, Atherotech, Daiichi Sankyo, DTC MD, Esperion, GlaxoSmithKline, iMD (Intelligent Medical Decisions), Kinemed, LipoScience, Merck, NovoNordisk, Roche, Sanofi-Aventis, Synarc, Takeda, Vindico Medical Education
Grant/Research: Abbott, Daiichi-Sankyo, GlaxoSmithKline, Merck, Roche
Board of Directors: DTC MD, Omthera, Professional Evaluation, Inc. Medical Education Company, Sonogene

William Elliott, MD
Royalty: Elsevier
Fees for Non-CME Services: Forest Laboratories, Takeda Pharmaceuticals North America
Contracted Research: Forest Research Institute
Other (Editors Honoraria): Elsevier, Springer

Stanley Franklin, MD
No relevant financial relationships to disclose.

Richard J. Glassock, MD
Consultant: Bio-Marin, Bristol-Myers Squibb, ChemoCentrix, Eli Lilly, FibroGen, Genentech, Lighthouse Learning, National Institutes of Health, Novartis, QuestCor, Wyeth, Vifor,
Ownership Interest: La Jolla Pharmaceuticals, Inc., Reata, Inc.
Board of Directors/Advisors: Wyeth

Peter Kowey, MD, FAHA, FACC, FHRS
Consulting Fees: AstraZeneca, Boehringer Ingelheim Bristol-Myers Squibb, Daiichi Sankyo, GlaxoSmithKline, Johnson & Johnson, Merck, Sanofi-Aventis
Fees for Non-CME Services: Boehringer Ingelheim, GlaxoSmithKline, Sanofi-Aventis
Ownership Interest: Cardionet

Peter McCullough, MD
No relevant financial relationships to disclose.

Keith C. Norris, MD
Consulting Fees: Amgen, Davita, Takeda

Katrin Uhlig, MD, MS
No relevant financial relationships to disclose.

William White, MD
Consulting Fees: Takeda
Contracted Research: Pfizer
Other: Bristol Myers-Squibb (Safety Consultant)

External reviewer reports the following relationship(s):
Benjamin Ansell, MD
Consulting Fees: Genentech, Ortho-Janssen
Fees for Non-CME Services: Pfizer
Ownership Interest: Biogen, Amgen, Bruin Pharma

Vindico staff report the following relationship(s):
No relevant financial relationships to disclose.

The University of Chicago Center for Continuing Medical Education staff report the following relationship(s):
No relevant financial relationships to disclose.

Signed disclosures are on file at The University of Chicago Center for Continuing Medical Education.

Unlabeled and Investigational Usage:
The audience is advised that this continuing medical education activity may contain references to unlabeled uses of FDA-approved products or to products not approved by the FDA for use in the United States. The faculty members have been made aware of their obligation to disclose such usage. All activity participants will be informed if any speakers/authors intend to discuss either non-FDA approved or investigational use of products/devices.

Copyright Statement:
Created and published by Vindico Medical Education, 6900 Grove Road, Building 100, Thorofare, NJ 08086-9447. Telephone: 856-848-1000; Fax: 856-848-6091. Printed in the USA. Copyright© 2011 Vindico Medical Education. All rights reserved. No part of this publication may be reproduced without written permission from the publisher. The material presented at or in any of University of Chicago and Vindico Medical Education continuing medical education activities does not necessarily reflect the views and opinions of University of Chicago and Vindico Medical Education. Neither University of Chicago, Vindico Medical Education, nor the faculty endorse or recommend any techniques, commercial products, or manufacturers. The faculty/authors may discuss the use of materials and/or products that have not yet been approved by the US Food and Drug Administration. All readers and continuing education participants should verify all information before treating patients or utilizing any product.